Diagnostic device launches are expanding as global demand for early detection and testing continues to grow across hospitals, laboratories, clinics, and home-care settings. Rising chronic disease prevalence, preventive healthcare awareness, and the need for faster clinical decisions are encouraging companies to introduce advanced testing technologies in new markets. A structured market entry strategy is essential to assess regulatory approvals, diagnostic infrastructure, pricing, reimbursement, distribution channels, and provider adoption before launch.
An effective Diagnostic device market launch strategy helps companies reduce entry risks, improve clinical acceptance, strengthen commercialization planning, and scale diagnostic access across diverse healthcare systems.
The global diagnostic testing market reached around USD 207.96 billion in 2025 and is projected to surpass USD 281.56 billion by 2035. In-vitro diagnostics were valued at about USD 106.29 billion in 2025, while point-of-care diagnostics are expected to grow from USD 44.1 billion in 2025 to USD 85.2 billion by 2035.
How can companies build a diagnostic device market launch strategy for high-growth testing markets?
Companies can build a diagnostic device market launch strategy by assessing testing demand, regulatory pathways, pricing, reimbursement, laboratory readiness, provider adoption, distribution channels, competition, and clinical evidence requirements.
- Regulatory Pathway Planning: Identifies approval requirements, product classification, documentation needs, timelines, and compliance obligations before launch.
- Pricing and Reimbursement Review: Assesses affordability, payer coverage, hospital budgets, reimbursement options, and competitive pricing benchmarks.
- Laboratory Readiness Evaluation: Reviews lab infrastructure, equipment compatibility, technician skills, workflow capacity, and testing turnaround requirements.
- Distribution and Adoption Strategy: Plans channel partners, provider onboarding, clinical evidence communication, and launch sequencing for stronger market acceptance.
Nexdigm Advisory for Laboratory Readiness Assessment
Nexdigm Advisory for Laboratory Readiness Assessment helps diagnostic device companies evaluate lab infrastructure, equipment compatibility, technician capability, workflow capacity, quality processes, and turnaround requirements before launch. This enables companies to identify operational gaps, support smoother device integration, improve testing reliability, and strengthen market entry planning across target healthcare settings.
Nexdigm’s Role in Diagnostic device market launch strategy
Nexdigm’s Role in Diagnostic Device Market Launch Strategy includes assessing market demand, regulatory pathways, pricing, reimbursement, laboratory readiness, distribution channels, and adoption barriers to support successful diagnostic device commercialization:
- Finding the Right Market: Nexdigm helps identify where the diagnostic device is most needed, based on patient demand and healthcare gaps.
- Making Regulations Easier: Nexdigm supports companies in understanding approvals, documentation, and compliance steps before entering a new market.
- Setting Practical Pricing: Nexdigm helps create pricing that works for hospitals, labs, patients, and reimbursement systems.
- Preparing Labs for Adoption: Nexdigm reviews whether laboratories have the right infrastructure, trained staff, and workflows to use the device effectively.
Nexdigm’s case:
Nexdigm helped a diagnostic device company prepare its market launch strategy for early detection testing solutions. The assessment found that 58% of target laboratories needed workflow upgrades, 42% required staff training for device usage, and 35% had gaps in distribution coverage. Based on these insights, Nexdigm helped the company prioritize launch markets, strengthen lab readiness, identify channel partners, and build a phased commercialization roadmap for smoother adoption.
To take the next step, simply visit our Request a Consultation page and share your requirements with us.
Harsh Mittal
+91-8422857704